Seeking Alpha

Geron Corporation (GERN)

()

News & PR
Market Currents

Buzz
Twitter: GERN

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Wednesday Options Recap

Dec 2 • Frederic Ruffy • Comment!
BioMed Momentum Index: A Pause that Refreshes or More Pain to Come?

Oct 29 • Mike Havrilla • 1 Comment
Columbus Day Dash and Slash: DepoMed, Vivus, Oncolytics and RadNet

Oct 12 • M. E. Garza • 1 Comment
Stock Watch: BDSI, ACTC.PK, ONTY

Oct 11 • VFC's Stock House • 8 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Sep 20 • Justin M. Hall • 3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Sep 11 • Justin M. Hall • 23 Comments
Megatrend Companies Summary

Sep 10 • Bryan Gomez • 12 Comments
Cryo-Cell: The Stem Cell Sector's Profit Leader, Part 2

Aug 27 • M. E. Garza • 3 Comments
Cryo-Cell: The Stem Cell Sector's Profit Leader, Part 1

Aug 27 • M. E. Garza • 1 Comment
A Guide to Investing in the Next Decade

Aug 27 • Bryan Gomez • 2 Comments
Closing Update for Tuesday, August 18: Some Recouping

Aug 18 • Midnight Trader • 4 Comments
Tuesday Options Recap

Aug 18 • Frederic Ruffy • Comment!
Geron: Huge Potential in Oncology, Regenerative Med Pipeline

Aug 18 • VFC's Stock House • 2 Comments
Cash for Cardiovascular: Who Might Be Next?

Aug 12 • Michael Becker • 1 Comment
Wall Street Breakfast: Must-Know News

Jul 31 • SA Editor Rachael Granby • 14 Comments
3 Briefs to Open the Week

Jul 7 • VFC's Stock House • 16 Comments
Monday's Closing Update

Jul 6 • Midnight Trader • 5 Comments
Dealmaking Sweeps the Biotech Sector

Jul 5 • The Burrill Report • Comment!
Geron Pushes Higher on GE Healthcare Alliance

Jul 1 • Beacon Asset Managers • Comment!
Closing Update for Tuesday June 30

Jun 30 • Midnight Trader • Comment!
Tuesday Options Update: ELX, GERN, VALE, NVDA & EXC

Jun 30 • Andrew Wilkinson • Comment!
Adult Stem Cell Drugs and Therapies Are the Next Big Market

Jun 18 • M. E. Garza • 10 Comments
Geron's Risk-Reward Profile - Best in Biotech?

Jun 12 • Beacon Asset Managers • 14 Comments
Geron: Strong Investment in Human Embryonic Stem Cell Research

May 25 • Ryan Pollack • 15 Comments
Thursday's Options Recap

May 21 • Frederic Ruffy • Comment!
Where the Big Money Is Betting Big

May 15 • Andrew Mickey • 45 Comments
Latest Trend Leaders

May 15 • Trade Radar Operator • 2 Comments
Tuesday's Options Recap

May 12 • Frederic Ruffy • Comment!
Stem Cell Index Surges in Past Week

May 11 • Mike Havrilla • 3 Comments
Tuesday's Options Recap

May 5 • Frederic Ruffy • 1 Comment
Pre-Market Report: Stocks on Course for Lower Start

Apr 22 • Midnight Trader • 1 Comment
Reversal of Stem Cell Research Ban: 13 Stocks to Benefit

Mar 12 • Brian Dean • 9 Comments
Geron: The Excitement is Back

Mar 11 • Investment U • 2 Comments
Wall Street Breakfast: Must-Know News

Mar 10 • SA Editor Rachael Granby • 3 Comments
12 Stem Cell Stocks - Updated

Mar 9 • Stockerblog • 8 Comments
Cytori Therapeutics: Natural Play on Cosmetic Medicine

Mar 2 • Mike Havrilla • 3 Comments
Wall Street Breakfast: Must-Know News

Feb 27 • SA Editor Rachael Granby • 13 Comments
Friday's Options Recap

Feb 13 • Frederic Ruffy • 1 Comment
Thursday's Options Recap

Feb 12 • Frederic Ruffy • 1 Comment
Bullish Thesis for Biotech Remains Intact

Feb 5 • Michael Becker • 1 Comment
Geron Opens a New Era for Stem Cell Research

Jan 27 • Investment U • 4 Comments

Geron Corporation (GERN)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers